Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CAH Stock Forecast 2025-2026
$160.97
Current Price
$38.42B
Market Cap
Buy 12
Hold 4
Sell 1
Wall St Analyst Ratings
Distance to CAH Price Targets
+22.4%
To High Target of $197.00
+11.8%
To Median Target of $180.00
-21.0%
To Low Target of $127.12
CAH Price Momentum
-4.0%
1 Week Change
-0.3%
1 Month Change
+71.1%
1 Year Change
+36.1%
Year-to-Date Change
-4.4%
From 52W High of $168.44
+72.8%
From 52W Low of $93.17
📊 TOP ANALYST CALLS
Did CAH Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Cardinal Health is one of their latest high-conviction picks.
Latest CAH Stock Price Targets & Analyst Predictions
Based on our analysis of 23 Wall Street analysts, CAH has a bullish consensus with a median price target of $180.00 (ranging from $127.12 to $197.00). The overall analyst rating is Strong Buy (8.5/10). Currently trading at $160.97, the median forecast implies a 11.8% upside. This outlook is supported by 12 Buy, 4 Hold, and 1 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CAH Analyst Ratings
12
Buy
4
Hold
1
Sell
CAH Price Target Range
Low
$127.12
Average
$180.00
High
$197.00
Current: $160.97
Latest CAH Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CAH.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jun 13, 2025 | Morgan Stanley | Erin Wright | Overweight | Maintains | $181.00 |
| Jun 13, 2025 | Citigroup | Daniel Grosslight | Neutral | Maintains | $170.00 |
| Jun 12, 2025 | Evercore ISI Group | Elizabeth Anderson | Outperform | Maintains | $180.00 |
| Jun 10, 2025 | B of A Securities | Michael Cherny | Buy | Maintains | $170.00 |
| Jun 3, 2025 | Wells Fargo | Stephen Baxter | Overweight | Upgrade | $179.00 |
| Jun 2, 2025 | Evercore ISI Group | Outperform | Maintains | $0.00 | |
| May 5, 2025 | Morgan Stanley | Erin Wright | Overweight | Maintains | $166.00 |
| May 2, 2025 | UBS | Kevin Caliendo | Buy | Maintains | $170.00 |
| May 2, 2025 | Baird | Eric Coldwell | Outperform | Maintains | $170.00 |
| May 1, 2025 | Citigroup | Neutral | Maintains | $0.00 | |
| Apr 29, 2025 | UBS | Kevin Caliendo | Buy | Maintains | $160.00 |
| Apr 11, 2025 | B of A Securities | Michael Cherny | Buy | Maintains | $155.00 |
| Mar 31, 2025 | Mizuho | Steven Valiquette | Outperform | Maintains | $150.00 |
| Feb 5, 2025 | Jefferies | Brian Tanquilut | Buy | Upgrade | $150.00 |
| Feb 4, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $136.00 |
| Feb 4, 2025 | JP Morgan | Lisa Gill | Neutral | Maintains | $145.00 |
| Jan 31, 2025 | Morgan Stanley | Erin Wright | Overweight | Maintains | $142.00 |
| Jan 29, 2025 | Wells Fargo | Stephen Baxter | Equal-Weight | Maintains | $135.00 |
| Jan 24, 2025 | JP Morgan | Lisa Gill | Neutral | Maintains | $142.00 |
| Jan 10, 2025 | Citigroup | Daniel Grosslight | Neutral | Maintains | $129.00 |
Cardinal Health Inc. (CAH) Competitors
The following stocks are similar to Cardinal Health based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
CAH
Cardinal Health
mkt cap
38.42B
Cardinal Health Inc. (CAH) Financial Data
Cardinal Health Inc. has a market capitalization of $38.42B with a P/E ratio of 25.2x. The company generates $222.29B in trailing twelve-month revenue with a 0.7% profit margin.
Revenue growth is -0.7% quarter-over-quarter, while maintaining an operating margin of +1.3% and return on equity of -26.5%.
Valuation Metrics
Market Cap
$38.42B
Enterprise Value
$45.50B
P/E Ratio
25.2x
PEG Ratio
18.6x
Price/Sales
0.2x
Growth & Margins
Revenue Growth (YoY)
-0.7%
Gross Margin
+3.9%
Operating Margin
+1.3%
Net Margin
+0.7%
EPS Growth
+93.9%
Financial Health
Cash/Price Ratio
+8.7%
Current Ratio
0.9x
Debt/Equity
-4.0x
ROE
-26.5%
ROA
+3.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Cardinal Health Inc. (CAH) Business Model
About Cardinal Health Inc.
What They Do
Provides end-to-end healthcare solutions.
Business Model
The company operates primarily through healthcare distribution and supply chain management, generating revenue by distributing pharmaceuticals, medical products, and laboratory supplies to hospitals, pharmacies, and healthcare providers. Their extensive services include inventory management and logistics optimization, which enhance operational efficiency for their clients.
Additional Information
Based in Dublin, Ohio, Cardinal Health is one of the largest pharmaceutical distributors in the United States, playing a crucial role in maintaining the availability of essential drugs and medical supplies globally. This positions the company as a key player in the healthcare infrastructure.
Company Information
Sector
Healthcare
Industry
Medical Distribution
Employees
47,922
CEO
Mr. Jason M. Hollar
Country
United States
IPO Year
1987
Website
www.cardinalhealth.comCardinal Health Inc. (CAH) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Cardinal Health (CAH) stood at $162.17, denoting a -1.27% move from the preceding trading day.
Jul 10, 2025
By Zacks Equity Research
Tale of the Tape
Is BioCryst Pharmaceuticals (BCRX) Outperforming Other Medical Stocks This Year?
Here is how BioCryst Pharmaceuticals (BCRX) and Cardinal Health (CAH) have performed compared to their sector so far this year.
Jul 07, 2025
By Zacks Equity Research
Tale of the Tape
Cardinal Health (CAH) Laps the Stock Market: Here's Why
In the closing of the recent trading day, Cardinal Health (CAH) stood at $164.93, denoting a +1.82% move from the preceding trading day.
Jul 03, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
Cardinal Health (NYSE: CAH) launched the One Voice Initiative, providing financial aid to state pharmacy associations to support independent pharmacists' advocacy efforts.
Why It Matters
Cardinal Health's initiative strengthens its position in the pharmacy sector, potentially enhancing relationships with independent pharmacists and improving market influence, which could positively impact stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors
3 days ago
Quick Summary
Cardinal Health (CAH) closed at $162.17, reflecting a decrease of 1.27% from the previous trading day.
Why It Matters
A decline in Cardinal Health's stock price indicates potential weakness, which may affect investor sentiment and trading strategies, impacting overall market perception of the company.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
Cardinal Health (CAH) is being evaluated for its potential as a strong stock choice for momentum investors.
Why It Matters
The inquiry into Cardinal Health's potential as a momentum stock indicates possible growth and trading opportunities, influencing investor sentiment and stock demand.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Cardinal Health (CAH) closed at $161.98, down 1.47% from the previous trading day.
Why It Matters
A 1.47% decline in Cardinal Health's stock price signals potential volatility, which may affect investor sentiment and future trading strategies.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
Cardinal Health (CAH) closed at $164.93, reflecting a 1.82% increase from the previous trading day.
Why It Matters
Cardinal Health's 1.82% increase signals positive market sentiment, potentially attracting more investors and influencing stock momentum.
Source: Zacks Investment Research
Market Sentiment:
Neutral
Quick Summary
Dividend stocks are popular with investors due to their potential for steady income and returns.
Why It Matters
Dividend stocks provide regular income and signal company stability, attracting investors seeking reliable returns, especially in volatile markets.
Source: 24/7 Wall Street
Market Sentiment:
Positive
Frequently Asked Questions About CAH Stock
What is Cardinal Health Inc.'s (CAH) stock forecast for 2026?
Based on our analysis of 23 Wall Street analysts, Cardinal Health Inc. (CAH) has a median price target of $180.00. The highest price target is $197.00 and the lowest is $127.12.
Is CAH stock a good investment in 2026?
According to current analyst ratings, CAH has 12 Buy ratings, 4 Hold ratings, and 1 Sell ratings. The stock is currently trading at $160.97. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CAH stock?
Wall Street analysts predict CAH stock could reach $180.00 in the next 12 months. This represents a 11.8% increase from the current price of $160.97. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Cardinal Health Inc.'s business model?
The company operates primarily through healthcare distribution and supply chain management, generating revenue by distributing pharmaceuticals, medical products, and laboratory supplies to hospitals, pharmacies, and healthcare providers. Their extensive services include inventory management and logistics optimization, which enhance operational efficiency for their clients.
What is the highest forecasted price for CAH Cardinal Health Inc.?
The highest price target for CAH is $197.00 from at , which represents a 22.4% increase from the current price of $160.97.
What is the lowest forecasted price for CAH Cardinal Health Inc.?
The lowest price target for CAH is $127.12 from at , which represents a -21.0% decrease from the current price of $160.97.
What is the overall CAH consensus from analysts for Cardinal Health Inc.?
The overall analyst consensus for CAH is bullish. Out of 23 Wall Street analysts, 12 rate it as Buy, 4 as Hold, and 1 as Sell, with a median price target of $180.00.
How accurate are CAH stock price projections?
Stock price projections, including those for Cardinal Health Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 14, 2025 2:25 AM UTC